Nasal cavity cancer
ICD-10 C30.0 · ICD-11 2C20

Treatment of Squamous Cell Carcinoma of the Nasal Cavity, Stage I or Stage II

Squamous cell carcinoma of the nasal cavity at stage I or stage II covers small to moderately advanced lesions. At these stages, established locoregional treatment options carry comparable curative potential, and clinical management is guided by how the disease responds to the initial approach.

Clinical Scenario

Stage I disease involves small lesions; stage II includes small and moderately advanced lesions. For squamous cell carcinomas of the nasal cavity at these stages, treatment preferences are either surgery or radiation therapy, which have equal cure rates.

Treatment Approach (partial overview)

When disease does not respond adequately to the initial treatment, a defined surgical or radiotherapy-based intervention is available as the next step. The specific choice depends on the modality used first and the clinical response achieved.

Complete decision pathway and full regimen available in the structured protocol →
Instant Access to Structured Evidence-Based Regimens

References

  1. For nasal cavity tumors (squamous cell carcinomas), treatment preferences are either surgery or radiation therapy, which have equal cure rates.
  2. Stage I disease includes small lesions.
  3. Stage II disease includes small and moderately advanced lesions.
  4. For disease that does not respond to radiation therapy, craniofacial resection.
  5. For disease that does not respond to surgery, radiation therapy.
View source ↗